日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Developing and validating a predictive model for all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease

建立并验证代谢功能障碍相关脂肪肝患者全因死亡率预测模型

期刊:Diabetology & Metabolic Syndrome
影响因子:3.9
doi:10.1186/s13098-025-01724-6
Zhang, Fan; Liu, Longgen; Li, Wenjian
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States

肌少症与代谢功能障碍相关脂肪肝患者肝纤维化进展的相关性：来自中国和美国两个队列的研究

期刊:Nutrition Journal
影响因子:3.8
doi:10.1186/s12937-025-01081-0
Zhang, Fan; Liu, Longgen; Li, Wenjian
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease

验证acFibroMASH指数对代谢功能障碍相关脂肪肝患者发生MASH风险的诊断准确性

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-025-03781-7
Wu, Yunfei; Han, Yan; Zheng, Liming; Liu, Longgen; Li, Wenjian; Zhang, Fan
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS

采用液相色谱-串联质谱法（LC-MS/MS）鉴定乙型肝炎病毒相关肝细胞癌患者血清胆汁酸谱的改变

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-024-05686-6
Dai, Sijia; Zhu, Jingfei; Chen, Xuqiong; Zheng, Liming; Li, Xiaoping; Liu, Longgen
肿瘤
肿瘤免疫
多发性硬化症
微生物学
细胞生物学
肝炎
发表日期：2024
文献求助 收藏

Non-invasive prediction nomogram for predicting significant fibrosis in patients with metabolic-associated fatty liver disease: a cross-sectional study

用于预测代谢相关脂肪肝患者显著纤维化的无创预测列线图：一项横断面研究

期刊:
影响因子:
doi:10.1080/07853890.2024.2337739
Zhang, Fan; Han, Yan; Mao, Yonghua; Zheng, Guojun; Liu, Longgen; Li, Wenjian
脂肪肝
代谢
发表日期：2024
文献求助 收藏

Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study

非侵入性标志物与非酒精性脂肪性肝病患者显著纤维化的相关性：一项横断面研究

期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S417754
Zhang, Fan; Han, Yan; Zheng, Liming; Liu, Jianhong; Wu, Yunfei; Bao, Zuowei; Liu, Longgen; Li, Wenjian
脂肪肝
发表日期：2023
文献求助 收藏

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores

对于伴有高肝细胞癌风险评分的乙肝病毒相关代偿性肝硬化患者，替诺福韦在降低肝细胞癌发生率方面优于恩替卡韦。

期刊:Therapeutic Advances in Chronic Disease
影响因子:2.8
doi:10.1177/20406223221102791
Huang, Yan; Chen, Lichang; Huang, Rui; Zhu, Chuanwu; Shang, Jia; Qian, Yunsong; Lian, Jianqi; Liu, Longgen; Jiang, Jianning; Liu, Chenghai; Gui, Honglian; Xie, Qing
肿瘤
肿瘤免疫
微生物学
肝硬化
细胞生物学
发表日期：2022
文献求助 收藏

Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers

基于血清标志物的肝细胞癌预测模型的构建与验证

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-022-02489-2
Zheng, Liming; Huang, Zeyu; Li, Xiaoping; He, Meifang; Liu, Xiaoqin; Zheng, Guojun; Zhou, Xike; Liu, Longgen
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure

血清抗核抗体的存在并不影响乙型肝炎病毒相关急性加重型慢性肝衰竭的预后

期刊:Canadian Journal of Gastroenterology and Hepatology
影响因子:2.3
doi:10.1155/2022/7981338
Lin, Lin; Lin, Bin; Lan, Qing; Liu, Longgen; Lu, Jianchun; Zhang, Xiujun; Zheng, Shuqin; Xue, Yuan
肝衰竭
毒理研究
肝炎
微生物学
发表日期：2022
文献求助 收藏

Clinical features and prognosis of COVID-19 patients with metabolic syndrome: A multicenter, retrospective study

COVID-19合并代谢综合征患者的临床特征和预后：一项多中心回顾性研究

期刊:Medicina Clinica
影响因子:2.1
doi:10.1016/j.medcli.2021.05.014
Wang, Jian; Zhu, Li; Liu, Longgen; Yan, Xuebing; Xue, Leyang; Huang, Songping; Zhang, Biao; Xu, Tianmin; Ji, Fang; Li, Chunyang; Ming, Fang; Zhao, Yun; Cheng, Juan; Chen, Kang; Zhao, Xiang-An; Sang, Dawen; Guan, Xinying; Chen, Xiaobing; Yan, Xiaomin; Zhang, Zhaoping; Liu, Jiacheng; Huang, Rui; Zhu, Chuanwu; Wu, Chao
代谢
代谢综合征
发表日期：2022
文献求助 收藏